国际麻醉学与复苏杂志   2023, Issue (6): 0-0
    
95%有效量罗库溴铵气管插管时丙泊酚抑制插管反应的半数效应浓度
张晓雨, 周进国, 滕金亮, 刘海平, 李国利, 袁莉, 张光信1()
1.邯郸市第一医院
Median effective concentration of propofol to inhibit intubation reaction during tracheal intubation with a 95% effective dose of rocuronium
 全文:
摘要:

目的 探讨使用95%有效量(95% effective dose, ED95)罗库溴铵气管插管时丙泊酚抑制插管反应的半数效应浓度(median effective concentration, EC50)。 方法 选择择期行术中喉返神经(recurrent laryngeal nerve, RLN)监测下甲状腺手术成年患者,依次静脉给予咪达唑仑0.03 mg/kg、芬太尼3 μg/kg、瑞芬太尼0.5 μg/kg,同时采用Dixon改良序贯法血浆靶控输注丙泊酚(设置首例患者丙泊酚血浆靶控浓度3.0 mg/L,浓度梯度0.2 mg/L)。静脉注射罗库溴铵0.3 mg/kg后,进行气管插管机械通气。插管后5 min内最高MAP和(或)最高心率≥基础值的120%视为插管反应阳性,反之为插管反应阴性。采用Cooper法评估患者的插管评分。记录患者麻醉诱导过程中的BIS值和脑电爆发抑制的发生情况。记录术后插管相关不良反应(呛咳、体动等)的发生情况。采用Probit分析法计算得出ED95罗库溴铵神经监测气管插管时丙泊酚抑制插管反应的EC50及其95%CI。 结果 共30例患者纳入本研究。所有患者在麻醉诱导过程中未见脑电爆发抑制的发生。所有患者插管评分均在6分之上,且插管反应阴性患者插管评分高于插管反应阳性患者(P<0.05)。插管过程中2例插管反应阳性患者出现呛咳、体动,其余患者未出现呛咳、体动。术后24 h内随访所有患者,均无声音嘶哑、呼吸困难、明显咳嗽、咽喉痛等气道相关损伤的发生。使用ED95罗库溴铵气管插管时丙泊酚抑制插管反应的EC50及其95%CI为3.523(3.310~3.796) mg/L。 结论 使用ED95罗库溴铵气管插管时丙泊酚抑制插管反应的EC50为3.523 mg/L,能够完善插管条件,抑制插管反应。

关键词: 甲状腺手术;气管插管;95%有效量;罗库溴铵;丙泊酚;半数效应浓度
Abstract:

Objective To explore the median effective concentration (EC50) of propofol to inhibit intubation reaction during endotracheal intubation with a 95% effective dose (ED95) of rocuronium. Methods Adult patients who were scheduled for thyroid operation under recurrent laryngeal nerve (RLN) monitoring were selected. They were intravenously injected in sequence with 0.03 mg/kg midazolam, 3 μg/kg fentanyl and 0.5 μg/kg remifentanil. Meanwhile, propofol was given through Dixon modified sequential plasma target‑controlled infusion (where the plasma target concentration was 3.0 mg/L of propofol in the first patient, with a concentration gradient of 0.2 mg/L). After intravenous injection of 0.3 mg/kg rocuronium, tracheal intubation and mechanical ventilation were performed. The highest mean artery pressure (MAP) and/or the highest heart rate≥120% of the baseline value within 5 min after intubation was regarded as a positive intubation response. Otherwise it was considered a negative intubation response. The intubation scores were evaluated by the Cooper method. The bispectral index (BIS) values and the occurrence of electrocardiogram burst inhibition during anesthesia induction were recorded. The adverse reactions (cough, and body movement, etc.) related to postoperative intubation were recorded. Probit analysis was used to calculate the EC50 of propofol in inhibiting the tracheal intubation reaction of nerve monitoring with an ED95 of rocuronium and its corresponding 95% confidence interval (CI). Results A total of 30 cases were included in this study. There was no electrocardiogram burst inhibition in all patients during anesthesia induction. The average intubation score of all patients was above 6, and the intubation score of patients with negative intubation response was higher than that of patients with positive intubation response (P<0.05). During intubation, two patients with positive intubation response presented cough and body movement, which were not observed in other patients. All patients were followed up within 24 h after surgery, with no reports of airway related injuries such as hoarseness, dyspnea, obvious cough, or sore throat. The EC50 of propofol in inhibiting the tracheal intubation reaction of nerve monitoring and 95%CI was 3.523 (3.310, 3.796) mg/L. Conclusions The EC50 of propofol to inhibit the intubation reaction during tracheal intubation with an ED95 of rocuronium is 3.523 mg/L, which can improve intubation conditions, and inhibit intubation reaction.

Key words: Thyroid surgery; Tracheal intubation; 95% effective dose; Rocuronium; Propofol; Median effective concentration